Other innovations
If your innovation doesn’t fit any of the active categories then this is the place to submit your innovation for feedback and the opportunity for wider adoption across the region.

Ideas (Publish, Detailed Submission)

Innovation 'Elevator Pitch':
We work to reduce unplanned hospital admissions. Proactive Health Coaching helps patients to better control their health and thus reducing non-elective care. Engaged patients seek care at the right place, helping the NHS use its resources efficiently
Overview of Innovation:
Health Navigator is dedicated to improving patients’ lives through digitally supported health coaching at scale which is underpinned by robust scientific evidence.
 
Our forward strategy includes delivering an effortless patient experience and a focus on the development of a range of digitised services. To enable this, we are transforming the ways in which we deliver our services.

One of our services is Proactive Health Coaching (PHC). PHC is a telephone-based health management service that improves patient health and quality of life, while ensuring that healthcare resources are spent as efficiently as possible.
 
PHC provides non-medical patient support to help patients understand their chronic conditions, plan their care and navigate an often-complex healthcare system.
 
By identifying those likely to see future avoidable unplanned care, a coach is able to proactively support the patient. Support including helping to stabilise their condition, feel more confident in managing their conditions and navigating the often-complex health care system, thus reducing the risk of unplanned care.
 

 
Our model is evidence-based and grounded in scientific research, supported by several successful randomised trials. In summary PHC uses a patented combined approach of:

1) a complex risk predicting algorithm to forward predict on a daily basis, patients which are at high risk of a non-elective admissions
2) to then provide a programme of individualised care to those at high risk using our nurse led case management programme.

The unique combination of the two provides the outcomes summarised below.

The end goals are:

1) To improve patient outcomes and reduce healthcare utilisation
2) To deliver operational efficiencies across the whole health system by reducing demand and avoidable admissions
3) To deliver a significant cost saving

Our company has successfully delivered this service to over 33000 patients in Sweden where we also conducted a randomised control trial with 12000 patients which statistically showed a reduction in healthcare utilisation by 30-50%. These results were published in the EJEM in 2013 and 2015.

We are now conducting another RCT in the UK with The Nuffield Trust as the principal investigator to replicate the Swedish results. We have over 7 CCGS already working with us and two years’ worth of data is showing statistically significant reductions of 30% in non-elective admissions and 36% in A&E attendances in the intervention groups.
 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Wellness and prevention of illness / Innovation and adoption
Benefit to NHS:

The intervention is co-created and patient goal focused.
 
First we get to know the patient during a face-to-face meeting with a health coach where we review the challenges the patient faces, agree on some shared goals and make a plan for the future.
 
Over the next 6-9 months, the coach and patient have regular contact as the patient continues to make progress. Over time, the patient becomes more confident about managing their own condition and seeking the right care, at the right time.
 
By the end of their coaching program most patients feel confident to continue independently. By this time, the risk of seeking avoidable unplanned medical care has decreased significantly.
 
Proactive Health Coaching is being delivered together with various CCG partners in England and will be evaluated by the Nuffield Trust on a yearly basis.
 
By supporting patients with weekly coaching calls, the randomised control trial with NHS Vale and York CCG is already showing high levels of improved patient experience, a reduction in attendances at A&E and fewer admissions to hospital. Patients being supported by their health coaching intervention are also reporting more confidence in the management of their conditions.
 
From a recent NHS Confed case study (June 2017), results collated by NHS Vale of York CCG are currently being evaluated and published by the Nuffield Trust, an independent health charity. In this early assessment of the trial, this case study covers 183 patients, of which 121 patients have had the support of a health coach, has yielded savings per patient in the first year of the intervention of £1,034 less than the control group. This means that the service is already close to break-even in its first year, as it costs £1,200 per person for a two-year intervention.
 
Moreover, there are the associated operational benefits from taking activity out of the system. In particular, the intervention group has had 63% fewer non-elective admissions and 60% fewer A&E attendances. The number of bed days was 17% less than the control group. The results also provide evidence of relevance, spread and replicability, with the initiative being easy to replicate, even in financially challenged care economies.
 
Recent results show a statistical reduction of 30% and 36% in non-electives and A&E attendances respectively. Since 2010 the Proactive Health Coaching service has helped over 15,000 patients to achieve better health, with 90% reporting that their health coach has improved their quality of life.
 
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
Proactive Health Coaching helps increasingly stressed health care systems.
 
We know that receiving the right care, at the right time is crucial to effective care, but navigating a highly complex health care system can often leave patients feeling overwhelmed or under treated, leading to repeated unplanned hospital visits or admissions. The stress on the system is apparent within emergency departments in the UK that are under increasing pressure as visitor numbers continue to rise.
 
But reports show that a lot of the health care we provide is avoidable. What’s more, the vast majority of resources end up funnelling to a small number of people. Health Navigator provides an evidence-based solution through non-medical, intensive, short-term coaching for patients with diverse and often complex health needs. Coaching results in reduced costs for this care heavy group and frees up much needed acute resources.
 
At Health Navigator, we have experienced nurses and AHPS working as health coaches who provide the support needed to understand health conditions, plan care, and enable patients to become more confident in managing their individual health needs.
 

 
The intervention is delivered in four phases.
 
Patient Identification: Identification through a predictive model to ensure the right intervention, to the right patients, at the right time.
 
Intervention: Non-clinical telephone-based intervention to empower the patient and improve ordinary care – so that avoidable care can be proactively prevented.
 
Evaluation / Monitoring: Continuous monitoring to ensure resource-efficient effort per patient.
 
Discharge: When patient is no longer in need of support a decision is jointly taken by patient and health coach to end contact.
 
Personal Health Coaching has the ability to significantly reduce avoidable healthcare consumption in the West Midlands, reducing costs and freeing up much needed acute resources. Latest results show a statistical reduction of 30% and 36% in non-electives and A&E attendances respectively. If scaled up across the West Midlands this could significantly reduce health inequalities, improve patient outcomes, reduce operational pressures whilst delivering a financial saving.
 
We are currently working with 3 CCG’s in the region and are seeking additional sites in the West Midlands to join our randomised control trial.

Current and planned activity: 
This is an exciting time for Health Navigator UK. We are encouraged by the progress we are making and are delighted to have secured a number of significant contracts to deliver new and innovative healthcare services in the UK.
 
Proactive Health Coaching is being delivered together with seven CCG partners in England and will be evaluated by the Nuffield Trust on a yearly basis. We are currently showing statistically significant reductions in the intervention group compared to the control of 30% in non electives and 36% in A&E attendances.
 
We are at the start of a significant growth phase but acknowledge we cannot do it alone and we are seeking additional sites in the West Midlands to work with.
 
If you would like to explore this opportunity please get in touch.
What is the intellectual property status of your innovation?:
Held by Health Navigator UK Ltd
Return on Investment (£ Value): 
medium
Return on Investment (Timescale): 
1 year
Ease of scalability: 
Simple
Read more
Hide details
Ravinder Sandhu 21/05/2018 - 10:52 Publish 1 comment
4.3
3
Votes
-99999
Innovation 'Elevator Pitch':
Our web based visualisations of NHS datasets is disrupting the analytics market. It allows systems to understand cause and effect within their health economies and test hypothesis in real time by interacting with the data through drop down menus
Overview of Innovation:
Our vision is to give every NHS system leader in England a clear picture of the end to end journey for the populations they serve. At the same time we aim to save the NHS £millions by disrupting the market for low level analytics!
The challenge currently faced by all healthcare leaders is a lack of insight and meaningful, consistently-reported analysis regarding the position and performance of the healthcare system. This lack of insight hampers the efficacy of the strategic and operational planning process and the scope and effectiveness of monitoring and oversight.
This challenge sits in the context of masses of existing publicly available healthcare data. Data that’s time consuming for providers to prepare but underutilised due to its format, shape and local capacity and capability.
Our vision is to make VUIT.ONLINE, our information and insight portal, available across the entire NHS in England. The tools we’ve developed allow users to interrogate data across an provider, CCG, ST or ICS quickly and efficiently in a way which informs decision making and allows the impact of interventions to be validated using existing national datasets.
VUIT.ONLINE re-configures, combines and visualises NHS and other national datasets in a way that allows them to be used to understand system and provider performance and demand in context.
Our front-end combines different datasets to create insights not available from any one alone, for example combining DTOC data with hospital bed-base to understand the effective scale of the DTOC issue, or comparing RTT data with consultant workforce to contextualise waiting list trends.
By doing this we can support system leaders to gain a deep understanding of cause and effect related to key strategic issues within their ICSs and model the impact of decisions they may wish to make to address those issues.
All this is achieved with data which is consistent across all providers, layered from multiple data sources and, most importantly is instantly available, at the national, regional and place based level for comparison and analysis through an online portal.
The impact of VUIT.ONLINE is not just the creation and availability of new insights from data, but the speed at which it can be manipulated to test hypotheses.The financial viability of VUIT.ONLINE comes from its ability to deliver this with an absolute lack of in-house or procured analytical or BI resource in the form of consulting and CSU costs which currently run into many millions.
Stage of Development:
Close to market - Prototype near completion and final form may require additional validation/evaluation and all CE marking and regulatory requirements are in place
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Clinical trials and evidence / Innovation and adoption / Person centred care
Benefit to NHS:
VUIT.ONLINE re-configures, combines and visualises NHS and other national datasets in a way that allows them to be used to understand system and provider performance and demand in context.
We do this in a pre-packaged but evolving, continuously-updated front-end combining different datasets to create insights not available from any one alone, for example combining DTOC data with hospital bed-base to understand the effective scale of the DTOC issue, or comparing RTT data with consultant workforce to contextualise waiting list trends.
By doing this we can support system leaders to gain a deep understanding of cause and effect related to key strategic issues within their ICSs and model the impact of decisions they may wish to make to address those issues.
All this is achieved with data which is consistent across all providers, layered from multiple data sources and, most importantly is instantly available, at the national, regional and place based level for comparison and analysis through a scalable online portal.
The impact of VUIT.ONLINE is not just the creation and availability of new insights from data, but the speed at which it can be manipulated to test hypotheses at system level from the system’s own, current data within existing national datasets.
The financial viability of VUIT.ONLINE comes from its ability to deliver this with an absolute lack of in-house or procured analytical or BI resource. A fundamental success factor for the implementation of this innovation is a reduction in the cost of low-level analytical support to the NHS in the form of consulting and CSU costs which currently run into many millions.
Initial Review Rating
3.00 (2 ratings)
Benefit to WM population:
By giving system leaders the tools they require to effectively build end to end, whole system pathways and commission them outcomes will improve for the people of the West Midlands. However the way in which our innovation VUIT.Online is configured this benefit is freely available to all health economies in England
Current and planned activity: 
We are currently mid way theought the second wave of Test Bed applications where we are both an innovator and a defined test bed partner with a West Midlands CCG
What is the intellectual property status of your innovation?:
VUIT. Online and it's intellectual property is owned by its co-founders. It is built on licenced propriatry software and uses national data sets which exist in the public domain
Return on Investment (£ Value): 
Very high
Return on Investment (Timescale): 
6-12 mon
Ease of scalability: 
Simple
Regional Scalability:
VUIT. Online uses national data sets, propriatery analytcal software and globally recognised web developer frameworks (wordpress). As such it is scaleable across the entire NHS in England immediately
Measures:
Measurable outcomes:
-reduction in spend on low level analytics in the NHS in england
-reduction in patient pathway costs as health economies understand whole system costs more effectively and plan ICS's on this basis
-Improved ability to scale innovation in healthcare by giving innovators access to data which will support, clarify and stratify the way in which they develop and take their products to market
Adoption target:
We aim to make the resource available to all NHS managers in England through sharing examples of best practice around the use of VUIT.Online
Read more
Hide details
Adam Townsend 25/04/2018 - 14:31 Detailed Submission Login or Register to post comments
6
1
Votes
-99999
Innovation 'Elevator Pitch':
Omnigen® is a unique ‘off-the-shelf’ transportable biological matrix that can be used as an effective surgical and in clinic regeneration therapy for a range of wound care and ocular surface disorders.
Overview of Innovation:
The ocular surface comprises the cornea, conjunctiva, eyelids and lacrimal glands, and any disorder in these structures can be classified as an ocular surface disorder (OSD). Though the prevalence of OSD is quite high, unfortunately, cases often go undiagnosed or undertreated, due to a lack of understanding of symptoms and inaccurate evaluation. As people are living longer, these disorders are becoming more prevalent, but awareness about them is limited.
 
Omnigen is an innovative sight saving and wound care regenerative therapy that retains the natural regenerative properties of fresh amniotic membrane (amnion) in a dry and stable transplant matrix. Omnigen equips civilian and military clinicians with an easy accessible and easy to use regenerative therapy, allowing them to effectively treat OSD and trauma in surgery, in the clinic or in the emergency room.
 
Omnigen is supplied in a bespoke delivery tray. It is easy to manipulate and applied dry, directly to the eye, where it can be rapidly rehydrated by ambient in vivo moisture of the eye. The epithelial side is marked for confident orientation.
 
Omnigen contains no viable cells. It is stored and shipped at room temperature (25˚C) and is ready to use straight from the sterile pack. There is no longer any need to be concerned with keeping amnion frozen, thawing it, having to pre-plan use or risk wastage.
 
Omnigen retains the originality of amnion. It is manufactured using a patented preparation and drying process (Tereo®). This process allows retention of the natural trophic components present in fresh amnion; an element believed to be linked to wound healing performance (Allen C.L., et al 2013).
 
Omnigen is a stable matrix developed so that it may be stored at the point-of-care. As a stock product, it is therefore ready to use immediately when clinically required. Omnigen can thus be routinely accessed in emergency situations to treat the diseased ocular surface.



Omnigen is processed from amnion donated by UK donors undergoing elective caesarean section births at NHS hospitals. Donor eligibility is assessed via the donor’s history, a face-to-face medical/social history interview and mandatory blood tests. Omnigen is aseptically processed under Grade A clean room conditions and undergoes antibiotic decontamination. The culture negative microbiological status of the processed product is validated by an independent laboratory prior to release.


 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Innovation and adoption
Benefit to NHS:
OSD (front surface of the eye) include a profile of blinding conditions that affect the cornea and conjunctiva. Omnigen is a sight saving and wound care regenerative therapy that is extremely convenient, easy-to-use, and effective in the treatment of OSD.

Why is amnion special: 

Amnion is the avascular inner layer of the foetal membrane which surrounds and protects the foetus during pregnancy. The amnion produces important proteins responsible for promoting the normal growth and development of the foetus [1]. 

These proteins exhibit immuno-regulatory [2, 3], anti-fibrotic [4, 5], anti-inflammatory, anti-angiogenic [6, 7] and wound healing characteristics. When appropriately preserved, the beneficial effects promoting wound healing can be maintained [8] to support improved regeneration of healthy tissue. Further to this, the foetal derived tissue [9] is immune privileged and therefore delivers a low risk of immunogenicity [2, 6].
 
Amnion has been successfully utilised for decades as an effective surgical adjunct for a wide variety of indications. However, its full potential has been limited due to its perishability, logistic challenges, and variability in the quality from piece to piece.
 
When applying the Tereo process to amnion, the amnion is carefully isolated from the placental mass with gentle ‘hands-free’ cleaning of the tissue to effectively remove any blood contamination. The process then implements proprietary steps to completely remove the irregular and inhibitory jelly-like substance on the stromal aspect of the amnion, the ‘spongy layer’. Researchers at Nottingham was the first to fully recognise the importance of removing the spongy layer, and therefore patented this process. The delicate Tereo drying procedure is a patented process that uniquely preserves the full complement of the aforementioned characteristics to deliver a high quality and enhanced therapy to the wound.
 
An extended series of Omnigen product sizes further allows surgeons to tailor their requirements on a patient-by-patient basis. This saves time previously spent adjusting the disc to fit the case, and reduces the amount of amnion that is to be discarded.
 
Currently, Omnigen is used surgically to treat OSD in hospitals UK-wide as a low-volume therapy. Our recent innovation to this is a novel surgical-free in-clinic application (OmniLenz®) that presents a unique opportunity to apply and retain Omnigen at the ocular surface without the need for surgery.
Initial Review Rating
4.60 (1 ratings)
Benefit to WM population:
Corneal scarring where the clear window of the eye becomes damaged from infection or inflammation is a leading cause of blindness worldwide. The cornea provides both protective and refractive properties essential for sight.
 
Treatment of OSD in the UK is the current target market. OSD requiring surgical intervention accounts for >700,000 cases annually. 12-13% of eye-emergency cases have corneal damage, and at an NHS emergency department, 6% (123,697) of cases were eye-related, 80% (96,048) of which were corneal abrasions or foreign body-related. Clinical opinion leaders estimate that with strategic clinical development, education, and training, the total market potential is £125 million, of which NuVision could access 26% or 101,681 cases (£33 million) annually, within 5-years. 
 
Historically, clinicians have faced major practical, and logistical hurdles when it comes to accessing amnion. Typically, amnion is stored frozen at -80°C. Shipping is an expensive challenge and the end user must use or dispose of the tissue within 48 hours of receipt. It is therefore not possible to stably transport the processed tissue over large areas, and access to remote and developing regions, where it is most needed is greatly restricted.
 
Omnigen is dry-preserved amnion, which can be easily stored and shipped at room temperature, and has a long shelf-life. Omnigen can therefore be shipped and accessed in any clinical environment, where can be used directly or stored for when it is needed. The outer packaging contains an inner sterile packet which is easily accessible and the disc is available for immediate use.  Omnigen will rehydrate with the fluid on the eye surface once applied.
 
The technology behind Omnigen has been developed to optimize convenient use for a diverse range of indications. Furthermore, Omnigen is pre-cut into discs, saving preparation time and reducing amniotic tissue waste, this could save resources from a two-fold perspective.
 
Omnigen is licensed for human application under the HTA, and is implemented, and priced, as a surgical adjunct in hospitals across the UK, this provides low barriers to implement its wider use. It is currently being used to treat patients across 30 NHS hospitals and private clinics, offering fast access to proven pain reliefOmnigen now has the potential to facilitate a faster response time to emergency cases, or response vehicle for immediate emergency use. 
 
Current and planned activity: 
NuVision has demonsrated clinical and commercial proof-of-concept with Omnigen in ophthalmology units of over 50 hospitals; a further 130 are being set up.  

 Required activity :
  • Complete set up of ALL NHS hospitals: Implementing NuVision onto procurement is a major barrier to Omnigen adoption.
  • Replace frozen amnion use: Requires educational development.
  • Broaden Omnigen application potential: Requires educational development.
The next clinical focus is chronic wounds; expanding Omnigen into a much larger therapeutic market would empower practice changing strategies to treat wounds more proactively and efficiently to help sustain a comprehensive high-quality NHS.
 
We are committed to continuously improving our market potential, and would be delighted to discuss usages and modifications of our current products for clinicians throughout the West Midlands to help develop an accurate business case acceptable to NHS trusts for implantation of Omnigen treatment solution.
What is the intellectual property status of your innovation?:
Background intellectual property (IP) pertaining to Omnigen development and manufacturing are the subject of a GB granted patent (GB2441939 - priority date 17-06-2006; granted 16-03-2011) and a GB priority (PCT) application PCT/GB2014/051722. The IP is owned by the University of Nottingham and exclusively licenced to NuVision, with freedom-to-operate.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
3 years +
Ease of scalability: 
Simple
Read more
Hide details
Dr Andrew Hopkinson 18/04/2018 - 13:34 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
Reduce the time it takes for clinicians to find clinical trial options for patients and increase trial enrollment rates.
Overview of Innovation:
It requires significant time to evaluate open clinical trials, analyse inclusion/exclusion criteria and determine a patient’s eligibility for trials based on all the relevant information in the medical record.
Watson for Clinical Trial Matching eliminates the need to manually compare enrollment criteria with patient medical data, making it possible to efficiently identify the potential trial options. It generates a ranked list of relevant trials for each patient

This increases patient access to clinical research, improves trial enrollment, and reduces trial delays.
See details and a video at: https://www.ibm.com/watson/health/oncology-and-genomics/clinical-trial-matching/
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Advanced diagnostics, genomics and precision medicine / Clinical trials and evidence / Innovation and adoption
Benefit to NHS:
Saves time in evaluating Clinical Trials available to your patients and their eligibility. Improves Trial enrollment rates - making new treatments available quicker for patients.
Initial Review Rating
3.00 (2 ratings)
Benefit to WM population:
Potential to be the first region in England to use this technology and make trials and new treatments available quicker for patients.
Current and planned activity: 
Currently deployed in healthcare outside UK. We are looking for organisations who will prove the solution works and delivers benefits in the UK.
What is the intellectual property status of your innovation?:
IP is IBMs
Return on Investment (£ Value): 
medium
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Read more
Hide details
David Clarkson 26/02/2018 - 13:46 Publish Login or Register to post comments
3
1
Votes
-99999
Innovation 'Elevator Pitch':
Watson for Genomics provides peer-reviewed, molecular evidence to help oncologists create personalized treatment strategies for patients based on results from genetic testing of tumour tissue.
Overview of Innovation:
Watson for Genomics analyses and categorizes genetic alterations that are related to cancer progression and provides a list of potential therapeutic options that target each alteration. The interpretation is done within minutes, and a comprehensive report is generated. The summary page of the report lists all the critical genetic alterations that were identified in the analysis and associates each with therapeutic options. Levels of evidence, extracted from relevant literature are provided to show the strength of the evidence.
Watson for Genomics presents findings with evidence via hyperlinks to sources for easy drill down. The drug report section provides details of identified drugs with overview, rationale for the association and level of evidence, as well as recruiting clinical trials.
The molecular profile interpretation provides in depth detail of the known genetic alterations found in the tumour sample. For each mutation, molecular and scientific evidence explaining the pathologic relevance of the alteration is provided. The diagram offers easy viewing of mutations with chromosomal location.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Advanced diagnostics, genomics and precision medicine
Benefit to NHS:
As sequencing becomes more cost-effective, larger gene panels/whole exomes and whole genomes will gain more traction. However, analysis of these will be a challenge, especially using manual methods of curation. Providing rapid cognitive insights to a molecular pathologist will allow genomic testing to become more pervasive and scalable.
Initial Review Rating
3.60 (2 ratings)
Benefit to WM population:
In conjunction with the West Midlands Centre for Genomic medicine, Watson for Genomics will allow genomic testing and personalised treatment options to become more pervasive and scalable in the West Midlands.
Current and planned activity: 
Watson for Genomics is deployed in US. We are currently discussing with several UK Trusts how to bring and prove it in the UK.
What is the intellectual property status of your innovation?:
IP of core product is IBM's
Return on Investment (£ Value): 
medium
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Read more
Hide details
David Clarkson 26/02/2018 - 12:26 Publish Login or Register to post comments
3
1
Votes
-99999
Innovation 'Elevator Pitch':
An online platform to recruit doctors and nurses for locum/temp shifts, and permanent shifts.  
Overview of Innovation:
MedicBank is an online platform to recruit locum and permanent nurses/doctors to hospitals, cutting the current high costs associated with traditional agencies. Nurses and doctors will be able to select shifts at immediate and elective notice, and matching AI software will aid this process to improve links between staff managers and their staff. This AI component will also help hospitals better understanding pricing by: times of the day, seasonal holidays, position and urgency.

The platform has been designed to improve the usability and interface between hospitals, their staff and future hires. Maintaining a real-time focus on intelligent pricing strategies and demand planning backed by our custom big data algorithms. The impact of this is seen on healthcare delivery. Hospitals will save a lot of money through our novel billing system, and this means that they can spend more directly on healthcare provisions. Furthermore, as a result of better staffing, patients will be seen sooner and should receive a higher quality of care.
 
 
Stage of Development:
Close to market - Prototype near completion and final form may require additional validation/evaluation and all CE marking and regulatory requirements are in place
WMAHSN priorities and themes addressed: 
Wealth creation
Benefit to NHS:
MedicBank has multiple benefits:
- Significantly more cost effective (up to 40%) due to our novel billing system
- Cheaper than existing traditional agencies
- Help solve short-term staffing problems (locum and temporary staff) as well as long-term recruitment issues (permanent staff)
- It targets both doctors and nurses. Other organizations have avoided focuses on nurse recruitment as this has significantly more administrative barriers to market.
- It reallocates the distribution of power from staff agency firms to the hospitals through unique features.
- This digitalizes the process of international recruitment of staff to help solve the issues underlying the staffing crisis.
Initial Review Rating
3.40 (2 ratings)
Benefit to WM population:
The societal need is a general improvement in healthcare provision. This includes:
o Reducing waiting times for emergency and elective procedures. More staffing in emergency departments will aid patients being seen within a reasonable time. This has further implications for elective procedures also.
o A higher quality of care that is associated with a fully-staffed healthcare team. When a ward is fully staffed, then patients receive a greater amount of care as there are more people to provide it. This means more time for patients.
o More available options due to reduced spending on staff (a lot of which goes to agencies and not to the staff). Trusts are limited by their capital and equipment, this leads to greater waiting times for patients.
o Happier staff will deliver better care. The current mood within the medical workforce is poor. They feel over-worked and targeted, and it is difficult for this not be translated into their work mood.
Current and planned activity: 
Our current plans are to engage with AHSN that are nearby to our current location (East Anglia/London) to try and commence procurement. 
What is the intellectual property status of your innovation?:
Code, AI, and undisclosed features are our IP.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
2 years
Ease of scalability: 
Simple
Read more
Hide details
Fawz Kazzazi 22/02/2018 - 18:27 Publish Login or Register to post comments
3
1
Votes
-99999
Innovation 'Elevator Pitch':
Feedback Centre enables organisations to collect feedback from any stakeholder. This information is presented via a visual dashboard called Informatics, allowing health organisations to spot trends & issues and act on them or plan improvements.
Overview of Innovation:
Feedback Centre has been developed in collaboration with and for the NHS and Health & Social Care organisations.

Feedback Centre brings together public feedback, survey results and complaints, all of which can be shared directly with stakeholders/service providers. This allows data from multiple sources to be joined-up, stored in one place and shared organisation-wide. 

Feedback can be collected online, including by tablet, mobile, Facebook and via widget, as well as via SMS and kiosk. This offers a great choice for patient engagement and allows patient experience teams to gain information from a broad cross-section of society, as different social, economic and clinical groups often communicate via very different means. The system also allows offline and archived feedback collected from other sources to be imported into Feedback Centre.
                                                                                                           
Feedback Centre also includes a screen-reading and translation feature with the aim of preventing the exclusion of those with visual impairments or poor literacy skills from engaging with providers.
 
Health & Service providers are able to respond publically to feedback, shortening response times to public concerns and reducing the volume of incidents that escalate to formal complaints.
 
Our business intelligence dashboard, Informatics, presents the fastest way possible for Health organisations/Trusts to access data, understand trends and create reports. It will also provide clients with the ability to utilise their own taxonomy, categorising the data in any format required. This allows for benchmarking of providers, services and departments, as well as identifying areas for potential improvement.

Utilising sentiment analysis, Feedback Centre will determine the emotional tone behind a series of words. This can be used to gain an understanding of the attitudes, opinions and emotions expressed within a review or complaint. Thus they can be weighted for seriousness and therefore flag providers to take note and take instant action
 
To ensure confidentiality the system is hosted by EKKO securely to NHS Trust information governance standards with monthly updates provided to the platform. 
 
To see Feedback Centre in action, take a look at the following video featuring Healthwatch and NHS England: http://www.EKKOmedia.com/healthwatch-video/
 
Benefits:
  • Branded system for any organisation
  • All information available in one place
  • Secure, ISO27001 Hosted Surveys and GDPR ready
  • Less risk, all information is shared directly with client only
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Wealth creation / Clinical trials and evidence / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
A single database for ALL experience data: The key benefit to the NHS is the storage of all user & staff experience data into a single database, which can be, used organisation-wide by an unlimited number of users with different levels of access. Hence this aggregation of data provides:

A facility removes the risk of inefficiencies due to having multiple, unconnected silos of disparate information, training is provided every step of the way by EKKO.
  • Peace of mind for GDPR compliance and ISO27001 hosting, utilising world leading hosting architecture Amazon Web Services.
  • An ability to create a snapshot or larger historic overviews of analysed data on single aspects or wider views of experiential data and trust feedback    
  • Services and providers to be benchmarked, allowing the identification of top performers or highlighting underperforming providers or departments. Alternatively it can show issues where quality or care does not match KPI’s, indicating a need for investigation or a comparison to be made. 
     
  • Creation of specific taxonomies; Trusts can categorise their data to ensure that the words and meanings meet that of their patients within in different clinical, social and ethical groups, so as to remove barriers whilst ensuring data integrity and meaning is maintained when analysed and reported on.
     
  • Through the multi-channel approach it allows Inclusivity and increased response rates while maintain data cohesion. Feedback Centre can be used to engage with a broader cross-section of society, resulting in higher response rates for surveys. e.g. young people and those within the working population are often unable to attend Patient Participation Group (PPG) meetings, meaning they are often under or not represented in survey results. Allowing those groups to complete a survey via a smartphone or Facebook application which increases the likelihood of gaining a more representative sample within the Feedback Centre database.
     
  • Cost savings on external surveys suppliers - The system can be used to administer the Friends and Family Test, as well as any other mandatory or ad-hoc NHS surveys, including staff surveys. Using the system for surveys removes the need for external partners to conduct surveys, hence a significant saving. (The system has no limit on users or the creation of custom surveys, thus no additional costs per survey). Whilst also ensuring all survey data is held by the Trust and in one place for future reference and analysis.

Initial Review Rating
4.80 (2 ratings)
Benefit to WM population:
How do the public see their responses or outcomes/results of feedback they give?



Give YOUR Patients & the Public a voice for feedback and complaints
We provide the WM population with a place to share feedback safely about services that they use. All health and care providers can feature on the system. Feedback is displayed publicly after moderation, allowing anyone to compare and benchmark providers based on real experiences.
 
The system is multi-channel, inclusive and easy to use
A significant proportion of the NHS’s engagement is done via Patient Participation Groups (PPGs). PPGs are not always representative re: age, race & gender, as well as numerous other demographic factors. This is due to people being unable to attend PPG meetings due to being at work, school or condition they are being treated for. By offering a multi-channel solution, members of the public are able to leave feedback online, increasing the likelihood of gaining direct feedback and insights from those groups. A text-reader service can be added to the site to enable those with visual impairments and speakers of other languages to give feedback.
 
Our technology can be used to broaden ways users engage in feedback. Thus we wish to work with health providers to explore & develop such processes & systems.
 
Provider responses
Service providers are able to respond to reviews publically or privately, addressing concerns before they escalate into serious issues or formal complaints. This demonstrates to the public that they are being listened to, inspiring confidence in services & can be used to intervene in more serious alerts & complaints.

Branded, secure portal
The system is branded to health clients’ guidelines to ensure uses have confidence with whom they are engaging with and responding too. Security and hosting is to NHS Trust IG standards with Amazon Web Services. All data is hosted in the UK and load-balanced, ensuring availability of systems at all times.
 
Using a secure, online portal offers a greater level of security than collecting data offline/paper, as well as providing significant cost savings. Currently, most patient experience data is collected and stored offline in a multiple, which has implications in terms of the GDPR regulations that come into effect in May 2018.
 
Monitoring & reporting on changes
Centralisation of cohesive data provides the ability to compare and contrast between service, timeframes and as a way of gauging and monitoring any changes that are made.
 
Current and planned activity: 
Current
We work with NHS trusts, CCGs, Healthwatch network & local. System is showcased at UK events with major update due -Feedback Centre 2.0. Long term aims are to roll-out across NHS, Care & Housing sectors

Regional Scalability
Explore West Mids roll out as it has not yet been scaled across an entire NHS region previously. NHS E & SWAHSN funded regional roll-out across 7 Healthwatch network organisations
 
Individual CCG, Trusts, STP, Healthwatch & GP federations uses are possible. Regional or large scale adoption could provide individual as well as wider insights to services & their performance & satisfaction levels.
 
Wish to hear from
Organisations wanting Feedback Centre demo: - GP, CCG, Trust or other health/social care provider
 
Evaluation & Validation of system benefits, monitoring delivery, ensuring + patient experience
 
Product Development – expand ways patients can engage & provide feedback
 
What is the intellectual property status of your innovation?:
Feedback Centre is copyright protected, having been created by EKKO. Data held within the system is the IP of the client, with EKKO performing the role of data processor.

Regulatory Approvals:
EKKO hold the following approvals: 

Cyber Essentials: EKKO have completed Cyber Essentials, a Government-backed, industry-supported scheme to help organisations protect themselves against the most common threats found on the internet.

GDPR Foundation Certification – EKKO have completed this certification with the aim of helping our clients prepare for the new regulation requirements.

Data Protection Public Register: ZA310893
 
IG Toolkit – EKKO are currently working towards the IG Toolkit and aim to have this completed by April 2018. 
 
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
6-12 mon
Ease of scalability: 
2
Read more
Hide details
Ian Hughes 15/02/2018 - 17:28 Publish 1 comment
5.5
2
Votes
-99999
Innovation 'Elevator Pitch':
Consultant Connect enables a GP to dial a single number to immediately reach an appropriate specialist.  Immediate Advice and Guidance is better for patients, clinicians & NHS. It is currently used in Elective, Urgent & Mental Health care settings.
Overview of Innovation:
Consultant Connect www.consultantconnect.org.uk is a simple CCG funded telecoms system that provides GPs with immediate access to telephone-based specialty mental health advice and guidance. By talking to a specialist, often whilst the patient is still in the surgery, the GP is better able to provide the right care first time to the patient, often avoiding an unnecessary referral or admission.  The specialist is based within a nearby NHS Trust Hospital.
 
GP calls connect directly, via a standard rate number, to teams of local specialists via their mobile phones with each specialist getting c 20 seconds to answer a call before it automatically forwards on to the next specialist. By connecting to teams of specialists, rather than to individuals, the connection rates are high.  The order in which specialists receive calls is based on a Rota of specialist availability that has been provided by the team. This rota can be either managed by us or by the team itself through an online portal.  The team of specialists are based in the local NHS Trusts.
 
Once connected, calls are recorded as highly encrypted, information-governed digital files which provide a medico-legal record which is available to the relevant GP practice and specialist team.  At the end of the call GPs are asked to stay on the line for a few seconds to rank the outcome – this gives the CCG a broad view as to the effectiveness of the system and their investment in it. Specialists are also asked to rank the outcome via text message as a back-up.
 
This service is in operation nationally across many specialties in physical and mental health.

In what instances should/can Consultant Connect be used?
The way in which this system is used is ultimately determined by the CCGs, Trust/Specialists and GP practices collectively, but it is generally accepted that calls will be made for patient-specific advice.
 
Within mental health we can connect GPs to the most appropriate mental health clinical professional (e.g. Psychiatrist, Psychologist, Cognitive Behavioural Therapist) to discuss issues such as:
  • Whether a referral is needed
  • Medication management/prescribing questions
  • Access to crisis support
We offer our service to best meet local needs between service users, GPs and Mental Health Trusts. 
 
We can tailor by service, specialty or pathway.
The speed of connection is such that the GP’s can (at their discretion) call whilst a patient is still with them.

Consultant Connect Service
https://www.youtube.com/watch?v=QWmNUubMCAE
 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Education, training and future workforce / Wealth creation / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
Why Trusts and CCGs work with us
  • Better patient experience – speeds up the care pathway, avoidance of unnecessary visits and contact with secondary care services, reductions in follow-up visits to GP Practices
  • Better GP experience – more patient episodes conclude with no follow-up work, case based learning, reconnecting with specialists
  • Better specialist experience – reduction in inappropriate referrals to secondary care services, reduction in the number of written requests for advice that require responses, reconnecting with GPs
  • Better for the mental health trust and CCG – full tracking of Advice & Guidance activity, greater ‘whole system’ efficiency, with savings available to support other hospital and community initiatives

How we perform
  • In Physical Health, across all elective care specialties, 66% of calls to Consultant Connect result in the patient avoiding a trip to hospital (referral or admission)
     
  • In Physical Health, across all of urgent care specialties, 27% of calls avoid a hospital trip that day (attendance or admission) and a further 36% of from A&E
     
  • In Mental Health, 39% of calls to our Mental Health Advice & Guidance line avoided a referral
 
What a Consultant Connect call has meant to …
… GPs
“The call enabled me to deal with some abnormal results in an efficient manner – which tests to request and what to do with the results. Saved a referral.”

… Consultants
“I took a call regarding a patient with syncope and ataxia. I avoided an unnecessary admission and got the lady seen urgently in an outpatient clinic.”

… Commissioners
“Consultant Connect is our only QIPP scheme that is over delivering against its YTD QIPP target. I’m genuinely struggling to know how to deal with all this positivity. It’s very unusual in my line of work. Great news.”
 
Testimonials:
https://www.youtube.com/watch?v=vEu7QDT4PzI
 
Initial Review Rating
4.80 (2 ratings)
Benefit to WM population:
Nearly 2,000 patients were spared an avoidable visit to hospital in the West Midlands by GPs who used Consultant Connect to contact specialists for immediate advice.
 
Doctors in the West Midlands turned to Consultant Connect, which allows them to speak to a specialist, often with the patient still in the room and can save them waiting days for a response or being sent to hospital for further checks.
 
Around 1,850 patients were spared going to Sandwell Hospital as well as Heartland and Good Hope Hospitals in Birmingham.
 
The service covers cardiology, diabetes and endocrinology, gastroenterology, gynaecology, general surgery, haematology, paediatrics, renal medicine, urology and respiratory medicine.
 
Since the phone line launched, GPs from 100 surgeries across Walsall, Sandwell and Solihull have made nearly 2,500 calls to specialists to get expert advice on the best care for their patients.
 
Consultant Connect estimates that West Midlands GPs and consultants have saved the NHS £570,000 by ensuring patients get the right treatment from the beginning.
 
When local GPs used Consultant Connect, around 50 per cent of their patients avoided the inconvenience of a trip to hospital.
 
Ref: Pharmacy Choice, 9 June, 2017
https://www.pharmacychoice.com/news/article.cfm?Article_ID=1832970
In one West Midlands CCG, the number of outpatient referrals dropped by 6 per cent over a three-month period.   This was Solihull CCG into HEFT (Heart of England Foundation Trust). 
https://www.consultantconnect.org.uk/breaking-news-ccg-establishes-consultant-connect-responsible-for-6-dip-in-referrals

We are currently working with the following CCGs in the West Midlands AHSN area:
 
Solihull CCG, Coventry and Rugby CCG, South Warwickshire CCG, North Warwickshire CCG, Worcestershire (South Worcestershire CCG, Redditch and Bromsgrove CCG and Wyre Forest CCG).  We are also working with the GP Federation Modality Partners in Sandwell.
 
We are working with the following Trusts:
  • HEFT - Heart of England NHS FT
  • SWFT - South Warwickshire NHS FT
  • UHCW - University Hospitals Coventry and Warwickshire NHS Trust
  • WAHT - Worcester Acute Hospitals NHS Trust
  • Sandwell and West Birmingham Hospitals NHS Trust - SWBH
  • George Eliot Hospital (GEH)
Current and planned activity: 
Current activity:
We are delivering Consultant Connect with over 45 CCGs across the UK, covering more than 12.8 million patients and over 1,700 GP practices.  To date we have handled 98,000 calls.

Planned/Required activity:
We would like to further roll out Consultant Connect to willing GPs and Trusts.  We would also appreciate any assistance in undertaking a formal return on investment review of our service to show very clear and robust data that we save money, and quickly.
 
What is the intellectual property status of your innovation?:
Consultant Connect Ltd own the telecoms system software and BI data reporting.
Return on Investment (£ Value): 
Very high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Read more
Hide details
Jenny Welling-Palmer 15/02/2018 - 13:38 Publish 1 comment
6
1
Votes
-99999
Innovation 'Elevator Pitch':
NATROX® Oxygen Wound Therapy is a medical device designed to heal complex non-healing wounds to improve healing outcomes and quality of life, optimise clinical and economic resources, and reduce diabetic foot related amputation rates.
Overview of Innovation:
NATROX® Oxygen Wound Therapy is a portable, lightweight and easy to use patient-friendly device, designed to topically deliver continuous pure humidified oxygen to the wound bed. The device was developed in order to help improve healing outcomes in wounds which traditionally remain static due to wound hypoxia (oxygen starvation), a common symptom of diabetic and vascular issues.

The NATROX® system is comprised of an Oxygen Generator, 2 rechargeable batteries and a single-use disposable Oxygen Delivery System.  The therapy is designed to be used 24/7 and as an adjunct to standard of care, such as absorbent wound dressings, with an average therapy length of 12 weeks. The product is supported by a growing portfolio of clinical evidence, including RCT-level data, which has demonstrated a significant increase in the healing rates of complex and non-healing wounds, compared to standard of care alone (90% healing with NATROX®  vs 30% for standard of care).
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Innovation and adoption / Person centred care
Benefit to NHS:
It has been shown that over £5.3bn is spent by the NHS each year on the management of 2.2m wounds. The management of non-healing wounds accounts for a significant amount of NHS resources (approx. £3.1bn per year) and is increasing due to an ageing population and higher rates of diabetes and diabetic foot ulceration.  NATROX® therapy is designed to positively impact healing rates and thereby optimise both clinical and economic resources used on non-healing wounds, in turn helping clinicians and financial decision-makers to access and treat a greater number of patients.

Furthermore, it is well documented that patient quality of life is negatively impacted by having a wound, and especially a non-healing wound, with increases in social isolation and depression across this patient population. NATROX® therapy focuses on healing wounds which are unable to heal with standard treatments alone, as these treatments are unable to address the underlying causes of non-healing wounds, such as oxygen starvation (hypoxia). The therapy system therefore focuses on providing pure humidified oxygen to hypoxic wounds, whilst being comfortable, quiet, lightweight and easy-to-use for the patient, allowing normal mobility without any negative impact from the device.
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
Increases in diabetes rates across the UK has in turn led to an increase in prevalence rates for diabetic foot disease and associated ulcers.  Furthermore, latest health economic evidence (e.g. Guest et al 2015 & 2017) has shown that non-healing wounds account for approximnately 57% of wounds at any time are deemed non-healing, which has a direct impact clinically, financially and to the patient experience.  Both minor and major amputation rates are increasing as a result due to the complexity of many diabetic foot ulcers, which has a significant impact on the health and wellbeing of these patients, with increased patient mortality following amputations of around 50% within 2 years.

Like many areas, the West Midlands is experiencing increased amputation rates, as a result of rising diabetes and diabetic foot ulcer prevalence.  This has a significant impact on the local health economy in the West Midlands area, especially in higher population bases such as city areas and surrounds.  Therefore, the adoption of NATROX® therapy across the West Midlands area could have a significant effect on helping to reduce non-healing levels within the diabetic foot ulcer population, and therefore positively impact the well documented clinical and economic cost that the burden of non-healing wounds brings with it.  

A resulting increased resource utilisation would allow a wider focus on the growing population of diabetic foot ulcer patients, improving clinical and economic output across local vascular, podiatry and wound management services.   
Current and planned activity: 
Inotec AMD is currently engaged with a variety of clinicians and decision-makers across the UK.  There are a number of local product evaluations active or soon to start, which will aim to demonstrate product afficacy in order to facilitate adoption of the technology locally and nationally.  in addition, a large NHS funded UK-based RCT is underway, which is due to report later in 2018.

Furthermore, the product is being reviewed both clinically and evidentially on a national level in both Scotland and Wales, where we are about to start a national clinical evaluation in Wales across both Welsh Podiatry and Tissue Viability networks, whilst in Scotland NATROX® therapy is being formally assessed by Health Improvement Scotland and the Scottish Health Technologies Group, in order to gain an official recommendation. 
What is the intellectual property status of your innovation?:
The intellectual property surrounding NATROX® therapy is owned by Inotec AMD Ltd.
Return on Investment (£ Value): 
Very high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Regional Scalability:
NATROX® Oxygen Wound Therapy is not yet adopted at scale within the UK, but is undergoing product evaluations with a view to contract listings and wider adoption.  A programme of marketing and events is planned to support the wider awareness and adoption of the technology.
Measures:
Further clinical efficacy demonstrated through local and national product evaluations, health efficiency data supported by the NATROX® Health Efficiency Model utilising local clinical data and outcomes, patient quality of life data from local and national product evaluations, and usability info from clinical usage.
Adoption target:
Availability of NATROX® Oxygen Wound Therapy on podiatry, vascular and tissue viability product formularies and listings in hospitals across WM region, for use on all clinically relevant non-healing and complex wounds. 
Read more
Hide details
Nick Howard 12/02/2018 - 18:23 Detailed Submission Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
The great, new, simple and inexpensive way for everyone to enjoy the decorative and therapeutic benefits of more colour in any medical outlet, via the existing suspended ceiling lighting modules.
Overview of Innovation:
This new, 21st Century innovation simply consists of square, acrylic panels that contain a basic but stylish design in an assortment of colours. These panels are easily fitted in minutes by any maintenance person, on-site, into the existing lighting fixtures, in front of the existing lighting modules – like a lens; in a suspended ceiling system.

When fitted in number across an area, they instantly transform that area, making it very pleasing and beneficial to both patients and staff. So helping to reduce the recovery time for patients, and improve the working conditions for staff and reduce stress levels; all via the Chromatherapy aspects of the product. (Google: the NHS ‘Lighting & Colour in Hospital Design’ Report, 2004 – PDF - Including the quotation by Florence Nightingale, page 6!).

However, by the same therapeutic element - delivered by this simple means – the product will also help to improve everyone’s health – especially, mental health – by the use of the same product in people’s everyday environment – offices, schools, etc. This then helping to avoid any medical treatment, in the first place? (Google: ‘Colour Therapy’).

A sort of secondary, background medical support in everyday life...so helping to reduce the burden on the NHS, altogether?

    
Plain white panels in current use.

       
Creative colour schemes can lead to more stimulating environments.

A properly designed visual environment, with the appropriate use of colour and lighting, will have important benefits in hospitals (see section 5.2). A relatively small investment in good, thoughtful colour and lighting design may reap major dividends over many years for patients, staff and visitors. To read the full Lighting and Colour for Hospital Design R&D Report by NHS Estates - click here.
Stage of Development:
Close to market - Prototype near completion and final form may require additional validation/evaluation and all CE marking and regulatory requirements are in place
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention
Benefit to NHS:
The product will improve patient recovery and contentment during their stay in hospital. (Likewise, whilst undergoing treatment via a surgery or other medical outlet).

So reducing their time spent in hospital, so reducing the strain on bed/treatment availability, for everyone. Similarly, the innovation will considerably improve working conditions and stress levels for all medical staff.
Initial Review Rating
2.20 (1 ratings)
Benefit to WM population:
Overall, the introduction of this inexpensive, new concept into all medical outlets in the West Midlands, will not only help to ease the strain on WM medical facilities but in doing so, will provide greater availability of medical care to all the West Midlands population.

Furthermore, as and when people need to go into hospital in the region, their stay will be far more enjoyable, their recovery time will be shorter, and they will be back at home with their families, far sooner than otherwise...so making room far sooner for other people.

The West Midlands Health Service then providing a pioneering, modern, innovative image to the rest of the medical field, throughout the Country/World. This being in the historically-inventive and innovative nature of the region. (More patent applications are submitted to The Patent Office at Newport from the West Midlands, than they are from anywhere else in the country!).

     
Current and planned activity: 
We are not currently engaging with the NHS. We are a small, creative company, presently, and have been busy finalising the product. One current requirement is for a pilot trial of the product in a suitable medical area.
What is the intellectual property status of your innovation?:
The simple but stylish design of the product is covered by a Registered Design at The Patent Office, Newport.
Return on Investment (£ Value): 
medium
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Regional Scalability:
The innovation can easily be scaled across the West Midlands, the UK, Europe, and beyond; all via the internet and the courier network. (The product has deliberately been designed to be fitted very easily by in-house, maintenance personnel).
Measures:
To see the product enjoyed and benefitted from in all medical outlets across the West Midlands, and beyond.
Adoption target:
All medical outlets in the West Midlands, and beyond, that have suspended ceiling systems.
Read more
Hide details
David Andrew Sidwell 12/02/2018 - 10:29 Detailed Submission Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
Simple visual tools that enable people who cannot communicate to convey the location and nature of their pain or discomfort. They can then be given appropriate support and treatment.
Overview of Innovation:
Many people suffering pain and discomfort cannot tell anyone about their distress. They may have a permanent or temporary communication difficulty, or they cannot speak English. Because of this, their pain and discomfort may be ignored.
 
Show Me Where is suite of simple visual tools that enable adults and children to convey the location and nature of their pain or discomfort. They can then be given appropriate support and treatment.
 
Show Me Where was created by Irene Hammond, a school nurse from the Hollies Special School, Cardiff for children with autism and speech disabilities. These children were unable to communicate pain and were impossible to examine because of anxiety or sensory issues. 
 
Since being introduced Show Me Where has been recognised as a valuable resource for a much wider range of people in a variety of settings including clinical, education and domestic.
 
Show Me Where is available in printed and digital app versions (via Apple and Google Play App Stores) for both children and adults. The apps also offer a range of languages to facilitate communication with non-English speakers. 
  • Arabic
  • Bengali
  • Polish
  • Somali
  • Urdu
  • Welsh
Show Me Where can be used with a wide range of people and in any setting:
  • Stroke   
  • Autism (ASD)
  • Dementia  
  • Disabilities e.g. CP, MS
  • Deafness and hearing problems
  • Intubated or tracheostomy
  • Trauma or anxiety
  • Non English-speakers
"We use Show Me Where as part of the Pain Assessment and Management Toolkit for Patients with Communication Difficulties in all clinical areas. We endorse its value in clinical practice." Sue Mogford, Lead Nurse, Pain Team, Cardiff and Vale UHB

The tools are very simple to use. Affected people are presented with a version of Show Me Where and asked if they are in pain. If ‘yes’ is indicated they are shown a list of body images to select from. Very quickly an accurate assessment can be made of the location and nature of pain and discomfort. Presenting the tool on a regular basis reduces stress and anxiety and ensures the early detection of pain with vulnerable people.
 
In a clinical environment it is helpful for family, friends and nursing assistants to triage individuals and therefore support a more rapid and effective examination by healthcare professionals. It also enables clinicians to inform the patient and gain consent for medical examination and interventions.

"This app is brilliant!" Sunshine Haskell BA Hons, PGCE Teacher, The Hollies Special School
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:
Many people suffering pain and discomfort are unable to tell anyone about their distress. They may have a permanent or temporary communication difficulty, or they cannot speak English. Because of this their pain and discomfort may be ignored. Show Me Where makes diagnosis and treatment more effective and efficient for health and social care professionals. It aslo improves the quality of life for individuals living with the pain and discomfort. Accessibility and parity are both improved.
Initial Review Rating
3.00 (2 ratings)
Benefit to WM population:
Many people suffering pain and discomfort are unable to tell anyone about their distress. They may have a permanent or temporary communication difficulty, or they cannot speak English. Because of this their pain and discomfort may be ignored. Show Me Where not only improves the detection, treatment and management of pain it makes diagnosis and treatment more effective and efficient.
Current and planned activity: 
Show Me Where has been available for some time via Cardiff and Vale University Health Board. They have entered a partnership with Focus Games Ltd to make the tools more widely available by promoting the tools more effectively. Show Me Where is officially endorsed by the following organisations
  • University Hospital of Wales (C&VUHB)
  • Llandough Hospital (C&VUHB)
  • St David's Children's Centre (C&VUHB)
  • Ty Hafan, Children's Hospice
  • Special Needs Schools in Wales
  • Welsh Ambulance Service Trust (WAST)
What is the intellectual property status of your innovation?:
IP is owned by Cardiff and Vale University Health Board
Return on Investment (£ Value): 
medium
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Regional Scalability:
Being widely used in hospitals and special schools in Wales.
Measures:
Improve the recognition of pain and its management among people with communication difficultis. Especially vulnerable groups.
Adoption target:
Ideally every organisation or individual that deals with people who have communication difficulties would use Show Me Where. There is no minimum viability level.
Read more
Hide details
Andy Yeoman 29/01/2018 - 08:52 Detailed Submission Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
A secure training platform using high quality video content and cutting edge learning technology. We produce high-quality courses, or update or convert your existing training material accessible via smartphone, tablet or computer – anytime/anywhere
Overview of Innovation:
The medics.academy platform has been designed with security to protect against inappropriate access and copyright infringement with an option to request users to pay per view.
medics.academy combines engaging content, low cost access and accessibility. Healthcare professionals from across the UK and internationally can benefit from consistent, sustainable educational programmes that will have a significant effect on performance and patient safety.
Medics Academy (MA) - Delivery Platform - Flow diagram
medics.academy (MA) - Delivery Platform

The platform incorporates unique technology to allow high quality video content to be viewed anywhere across the world without loss of quality. This allows educators, subject matter experts or partner organisations to securely distribute high quality, high value courses that may be of a sensitive, private medical nature. Programmes for or that target their audience whilst protecting their access to them and ensuring their ownership, IP and if required to generate direct income from their content.
 
Delivery facilities:
  • High quality education online on any digital device
  • Security and IP protection of authored content
  • Global access via a specifically designed IT platform
  • Scalability and sustainability via a revenue sharing business model
  • Tracking of users and access / usage
 
MA Content Production
The company mission is to empower health professionals through knowledge so they can provide better care. The company has already developed and delivered a range of courses

Content creation opportunities:
  • Content generation/production services and expertise
    • New Training Material creation
    • Conversion of existing material
    • Adapting original material for delivery via the MA Platform
  • Visuals graphics & animation facilities to illustrate points/information
  • Option to add additional products and services, e.g. link to classroom based training
  • Quality assured and endorsed content from experts combined with other content e.g. filmed demonstrations of skills

Company Background
The founders of the company, two medics, became increasingly frustrated by the poor design, use and engagement with e-learning and believe the use of these expert driven courses can be a part of a new blended learning solution to medical education.  From their frustration and experiences, they built a team based in the UK and the US, that have developed this platform. Medical educators can focus on building amazing content, supported by a team of artists, filmmakers, engineers and medical content specialists.

 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Education, training and future workforce / Wealth creation / Digital health / Innovation and adoption
Benefit to NHS:
Freedom of Access
Opportunity to train staff remotely at any time or place and at their own pace, the ability to deliver training content pre or post a course to either prepare or reinforce the material being delivered either as well or instead of a physically attending formal course. This secure training platform facilitates the trainer/education unit with a range of options to deliver their material to their staff and students.
 
This range of options can then be selected to best suit the ability to reach and gain access to the trainees e.g. it can facilitate them not travelling or leaving their place of work. It can be used to assist students with revision or reinforcement of a recently delivered course possibly before and exam or test.
 
This flexibility can work for the participant as well as the deliverer of content all leading to a better trained and confident workforce. Hence facilitating performance improvement and make training significantly more cost effective and efficient.
 
Usage Tracking
Material accessed can be logged along with information on viewer and duration. This is part of our security and revenue system when required and when this may be appropriate. This also gives content producers a clear idea into their most used and valuable training assets.  
 
Confidentiality & Control
Access to material can be controlled you may wish to do this to ensure that content that may be clinically sensitive (e.g. of distressing or of a possible sexual nature) or that may be commercial sensitive is not accessible by those without permission. 
 
Revenue Generation
Courses that are delivered on the platform can be via a pay per view option. This is a revenue sharing model between Vopulus and the content provider, so significant income generation can be earned by the training provider from offering their material to a global audience. We take away all the strain and complexities of an organisation creating a charging system and the processes to providing a secure and trusted credit cards charging system.
 
The Key Benefit
All you need to worry about is the material you wish to teach – we can produce that material with you and then deliver it safely to your intended or your selected audience.
 
We look forward to your call or your response below.
Initial Review Rating
3.40 (1 ratings)
Benefit to WM population:
Key Benefits
  • Simple Video Delivery Training Platform designed for Medical Content  Removes concerns over access and can form part of a library of material for a Trust or for West Midlands NHS & Community Clinical staff
     
  • Options to generate revenue from your content
    Generate money from external organisations or clinicians from your training material
     
  • Confidential and professional Training Material production or conversion
    Take the worry away from delivering, recording and illustrating your training material we will do that and if you’re not confident or comfortable being videoed we can arrange for an expert presenter to deliver your lessons
 
Enhanced Staff - Leading to better informed and trained healthcare professionals which ensures confidence that leads to improved patient safety and outcomes.
 
Training / Testing Freedom - Ability to offer courses to hard to reach clinical and medical staff due to their location (e.g. Community based) or their availability (shortages but imperative that they are brought up to date on a process or procedure). The platform allows 24/7 access to material and through the tracking a degree of confidence can be had by the trainers / management that the viewer has seen and understood the material delivered. The level of understanding can be confirmed via an online test or other assessment methods.
 
Potential Patient Use - This platform also has potential to be used for patient education programmes providing a significant increase in patient empowerment, self care and wellness.

Payment Security
The platform has a fully integrated payment system built on the industry leader Stripe. We also use a cutting edge ledger and tracking function that allows fully transparent tracking of payments for clients. Thus due incorporated Stripe system, partners/clients can be fully confident in a global payments and payment tracking system that utilises the latest technology and security standards.
Current and planned activity: 
Current Activity
  • We have a regional project underway with the West Midlands AHSN to produce training material for LTC.
  • We are having a number of discussions and negations on material related to maternity with Trusts across the UK.
  • Although we seeking to engage with more content providers and potential purchasers of group courses.
Thus we would like to discuss:
  • Procurement / Adoption of:  
    • More medical training Video productions or for more Trusts and other clinical training organisations/units to our Medical Academy Platform to deliver you material   
    • Usage of our secure and / or revenue generating video content Delivery Platform space. 
What is the intellectual property status of your innovation?:
Platform has IP associated with its design and security to protect content from plagarism.
The course content IP remains with the author apart from our newly produced graphics.
 
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
6-12 mon
Ease of scalability: 
Simple
Read more
Hide details
Johann Malawana 27/11/2017 - 14:55 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
Our award winning, low cost, high impact Patient Care Packs have been developed in collaboration with over 50 NHS Trusts to address the most common needs of patients and free up front-line staff time to spend on nursing and compassionate care.
Overview of Innovation:
Patients are often admitted to hospital at short notice. This means that some come ill equipped for their stay without event basic hygiene essentials, at what is often a confusing and difficult time.
 
Evidence indicates that nurses spend more than 5 minutes per patient obtaining essential items, or people survive without, having a negative impact on their well-being and impeding nursing ability.
 
Patient Care Packs (PCP’s) include essential items (such as toothbrush, toothpaste, grip socks, ear plugs and eye mask) everything a patient needs for their own personal hygiene, protecting their dignity and enhancing the feeling of comfort.


 
Our in-house assembly offers the flexibility to tailor packs to your specific requirements and include maps, questionnaires and information about staff and facilities, which will free up staff time to spend on nursing and compassionate care.
 
University of Leicester research proves that patient care packs save nurses more than 40 minutes per shift (1:8 patient ratio) enabling more effective nursing and saving the cash strapped NHS £1,705 per band 4 nurse. Read a two page summary of the research study or download the full report here.
 
Key findings from the research study conducted by the University of Leicester include:
 
94% of patients felt that PCP’s ensured they felt cared for during their hospital stay.
 
84% of nursing staff felt that PCP’s saved them more than 5 minutes per patient, releasing at least 40 minutes per shift, improving job satisfaction for 9 out of 10 nurses.
 
93% of nurses felt that PCP’s promoted positive interactions with patients.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Innovation and adoption / Person centred care
Benefit to NHS:
The HSCIC Indicator Portal Website show emergency hospital admissions (all conditions – data for 2014/15) in England as 5,131,589. Source: https://indicators.hscic.gov.uk/webview/
 
Hospitals have also experienced increases in the number of emergency admissions of older patients, by 18% between 2010-11 & 2014-15. Source: http://bit.ly/2tuy9we
 
The use of Patient Care Packs (PCP’s) provides tangible benefits for NHS Trusts through cost savings in procurement compared to competitor products, releasing nursing staff time and reduced demand on storage space.
 
PCP’s are essential toiletries available in one pre-packaged, easy-to-store, easy-grab pack. Receiving a pack improves the admission and care experience for even the most isolated and vulnerable patients.
 
PCP’s were piloted back in 2007 at the request of Leicester Hospital’s Chaplaincy, who were concerned that patients were being admitted with no basic care items and didn’t have family or friends nearby who could bring them essential items in an emergency situation – people like the elderly or homeless.  Staff may have had a few supplies, but these always ran out very quickly and then considerable nursing time was being expended in trying to obtain essential items for patients. A 3 year investment from the Department of Health in 2012 launched Personal Care Packs as a national social enterprise scheme.
 
PCP’s are viewed positively by nursing staff due to their role in conveniently and efficiently enhancing the quality of care to patients.
 
Patients also view PCP’s positively, perceiving that they improve their comfort, dignity and promote a feeling that they are being cared for.

Initial Review Rating
3.93 (3 ratings)
Benefit to WM population:
The HSCIC Indicator Portal Website show emergency hospital admissions (all conditions – data for 2014/15) in the West Midlands as 590,475. Source: https://indicators.hscic.gov.uk/webview/
 
The use of Patient Care Packs (PCP’s) provides tangible benefits for NHS Trusts through cost savings in procurement compared to competitor products, releasing nursing staff time and reduced demand on storage space.
 
PCP’s are sold to NHS Trusts through a social enterprise with the profits used to support the charity Giving World. These packs are distributed by nursing staff to the patients at the point of admission.
 
The attached research study conducted by the University of Leicester reported Nursing staff that use PCP’s found them beneficial in discharging their duties, enhancing the care they provide as well as leading to an increase in their job satisfaction through better patient-nursing staff relations. The use of PCP’s enables nurses to save time in performing their duties, relieving them of an administrative and logistical burden.
 
The report indicates that this time saving can be used to off-set the overall cost of the pack. The research has also provided an evaluation of the financial value of PCP’s when compared to alternative care packs. The compact nature of PCP’s also provides additional benefits in the space required to store the items.

The packs are proven to save 40 minutes per shift (assuming 8 patients cared for per shift), equating to between £8.58-£14.77 for band 4-7 staff.

Cost of 8 standard packs per shift (1 per patient) is £7.60, resulting in a saving of between £0.98-£7.17

Current and planned activity: 
We are the supplier of choice to over 50 Hospitals across the UK for customised patient care packs, including Guy’s & St Thomas’ Hospital’s Award-Winning Patient Pack. 100% of profits go to helping people living in poverty right here in the UK.
 
We would like WMAHSN to help to identify opportunities to offer Patient Care Packs to NHS Trusts in the region, enhancing the care they provide to patients by protecting their dignity and providing a feeling of comfort, as well as helping to increase the job satisfaction of nursing staff through better patient-nursing relations.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Read more
Hide details
Sujata Sabharwal 06/11/2017 - 10:35 Publish Login or Register to post comments
5
1
Votes
-99999
Innovation 'Elevator Pitch':
The Hydrant is a novel and effective solution of proviiding fluids to those patients with poor mobility or requiring flat-bed rest. it consists of a bottle and drinking tube that can be postioned to allow the patient to independently consume fluids.
Overview of Innovation:
 Within the NHS dehydration remains a significant problem with recent reports suggesting it may affect as many as one in seven hospital patients and cost the NHS £1 billion a year. The majority of hydration in secondary care, is reliant on patients’ independent consumption of fluids.One way to improve hydration amongst these groups of patients is to increase accessibility of fluids using drinking aids. These aids encompass a broad range of products from insulated mugs that maintain drinks at the appropriate temperature to more complex devices designed for patients who find it difficult to drink from standard vessels. it consists of a bottle with an adjustable, self-supporting drinking tube with a bite valve that allows patients to draw fluid from the device. The device has won design awards and offers a sensible solution to providing fluids for those patients with poor mobility or physical capacity, or otherwise confined to flat-bed rest. The bottle has been trialled on the Neurosurgery ward at UHB and was greeted favourably by staff and those patients offered it. 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Wealth creation / Innovation and adoption / Person centred care
Benefit to NHS:
Within the NHS dehydration remains a significant problem with recent reports suggesting it may affect as many as one in seven hospital patients and cost the NHS £1 billion a year (Good, Richard 2014) with elderly patients particularly susceptible due to their diminished thirst sensation and changes in kidney function (Hooper 2014).  The majority of hydration in secondary care is reliant on patients’ independent consumption of fluids.  The act of drinking appears a straightforward response to a physiological need yet it is in fact a complex behaviour determined by a variety of factors and their interactions (Koster 2009) including physical, psychological, and environmental influences (Kenney 2001). In the ward environment patients rely on the support of health care providers and yet staff frequently report a number of barriers to performing hydration care with insufficient time as a key barrier amongst them (Simmons 2001; Mentes, chang 2006). This can leave patients with limited movement, cognitive ability or higher clinical dependency particularly vulnerable to dehydration. One way to reduce this risk is to increase accessibility of fluids using drinking aids such as the Hydrant. 
Initial Review Rating
4.00 (2 ratings)
Benefit to WM population:
As above
Current and planned activity: 
The primary issue with its upatke within UHBFT was the availability of the device. Staff on wards where patients would benefit from its use were unable to procure the device.
We propose that WMAHSN facilitate a series of meetings with key staff involved in procurement at the hospital to improve the supply and availability of the bottle.
Once the bottle is more freely available we propose to raise awareness of its availability with staff on the relevant wards.
 
What is the intellectual property status of your innovation?:
Licensed product of Hydrate for Health Ltd,
http://www.hydrateforhealth.co.uk/our-products/the-hydrant/
 
Return on Investment (£ Value): 
N/A
Return on Investment (Timescale): 
N/A
Ease of scalability: 
Simple
Read more
Hide details
Ian Litchfield 03/11/2017 - 12:18 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
LocumTap is a flexible software solution for the booking, management and control of temporary clinical staff within hospitals and other clinical settings with proven cost savings.
Overview of Innovation:
LocumTap is the key to managing and controlling costs of locums within Acute care, moving from using Agency to Trust staff.
The system provides a real-time two way Locum booking system consisting of: a Clinician App and Web portal for HR or Bank Staff administrators. It has been designed by clinicians within the Acute settings, who understanding the operational needs & requirements of Hospitals, their departments & their staff, with fully configurable operational flexibility built in from the onset.

Controlled and Simple Administration
LocumTap improves adherence to standard operating processes, whilst providing flexibility to facilitate the nuances of specialist departments.
It is a complete Locum booking process which reduces & simplifies the administration burden whilst providing financial insights for the control of the temporary staffing. Providing: Staff details, Vacancies, Bookings, Pay-role reports etc.

The system allows for rapid upload of bank staff to initiate the system. Staff who request to join the Bank staff, upload their personal & professional credentials via the App, prior to undertaking a Trusts HR/Bank validation /acceptance process.
Customisation - Departments can specify their requirements, such as allowing any suitably qualified staff to fill vacancies, or requiring to approve any applicants prior to dept acceptance, as well as further approving any shifts they wish to work. Allowing Clinical managers to have full confidence in the staff hired to work in their discipline/Dept.
 
Benefits for Trusts and Locums
LocumTap provides a two way operation; Either locums can browse shifts and book shifts which match their credentials on-demand or elect to fill future shifts. Thus clinicians can plan ahead, control their time and manage their finances & work-life balance. Their shift information is recorded via Paperless Timesheets - Clinicians get a digital sign-off on their app for payment processing;
or through the Bank service indicating their shift vacancies Bank Admin can also look for suitable staff from a large repository of staff who can cover shifts and directly contact them via the App dramatically minimising the hiring of Agency.

All shifts vacancies can be seen – transparency. This has meant system has proved to be liked by staff as they feel in control and it has increased vacancy shift fill rates from 60% baseline to 98.5%. This is equivalent to £750,000+ per year in cost benefit to the trust (from junior doctor shifts alone).
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Wealth creation / Digital health / Innovation and adoption / Patient and medicines safety
Benefit to NHS:
LocumTap primarily targets hospital efficiency & reduction of Agency spending, but could equally be used by smaller clinical establishments.
 
Automated and Streamlined Service
Cost Benefit
  • Reduction in Workload of HR (by reducing the administrative burden of managing the bank). Removal of inefficient and unreliable methods of communication, such an end to interrupting clinicians with numerous cold calls and emails to establish availability and to firm up bookings.
Quality
  • End to Mistakes due to human error & associated costs.
    Paperless Timesheets and pay-role outputs for finance, has meant less errors and thus  a reduction of Admin and Finance time dealing with payment queries & disputes
Morale Increased
  • Less Workload for staff bank – chasing and making changes to information
  • Minimum Admin Stress – removal/ reduction of time pressure
  • No high Staff turnover due to removal of pressure.
  • Ability to take on other productive tasks – e.g. recruitment drives
     
Recruitment Support
Cost Benefit
  • Increase of clinicians in staff pool – Flexibility, Personal Control & Transparency led to 38.5% increase of self electing Clinicians joining
  • Competition for available shifts – leading to early booked shift vacancies
  • Competitive adjustment of hourly rates – Staff selecting their own pay-rate (in Confidence)
     
 
Quality
  • Increase of Full shift coverage – leading to less HR staff stress but also increasing hospital capacity and reducing clinical / ward staff stress
  • Increasing the Choice for HR staff due to large pool of Trust staff being available
 
Reduced Reliance on Agencies
Cost Benefit
  •  Major Efficiency of spend - Cost benefit of £15,000 and £20,000 per mth for every 10% conversion of doctors and nurses respectively from agency to bank staff. Est. saving of £750,000+ per year in costs (from junior doctor shifts alone).
Quality
  • Consistent and trusted locums – Staff who know the hospital systems, procedures and protocols
  • Less opportunities for errors due to unfamiliarity with the hospital or insufficient induction
Morale
  • Greater Cross-cover for unfilled gaps in the rota – ability for staff to gain new experiences and insights
 
Real-Time Data
Cost Benefit
  • Increase in Proactive planning – Wards, Departments and Locums selecting their preferred shifts - Gamification
  • Available shifts publicised in advance of agency – Internal covered minimising need for Agency staff weeks before required (creating time to negotiate?)
Quality
  • Better Management oversight on locum activity and spend
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
Although our innovation does not impact on patient safety directly, it can greatly impact of the care provided by ensure staff levels are maintained and that staff that know the hospital and the hospital them are in attendance. The evidence in the literature is patchy, although it is conventional wisdom that wards are more effective when appropriately staffed and bank staff are more efficient than external agency staff (the latter are less familiar with hospital processes, guidelines and IT).
 
The results from our current work at Chelsea-Westminster demonstrate higher staffing levels and also greater utilisation of bank staff rather than external agency staff with significant Cost savings.
 
 
The application of our technology could also be applied across Trusts with multiple sites where staff may be able to work in multiple locations or only within one or more locations. Thus this greater pool of Bank/Locum staff to draw upon should increase efficiencies and cost savings from Agency staff hire as well as reduce / remove any issues due to temporary staff not being familiar with the hospital, ward or their procedures and practices.
  
Within the Management Function it facilitates (Not covered above):
  • Better Recruitment Support - The platform has a recruitment tool to manage candidate applications - onboarding and verifying new locums.
  • Efficiencies of a Streamlined Service - Platform streamlines the entire shift booking cycle & improves adherence to operating procedures and policies.
  • Insights via Feedback and Rating System - Clinicians can be scored on their care quality, communication and punctuality. To ensure quality control and rehire-ability.
  • Informative Powerful Dashboards - Data is presented in dashboards, providing management with real time insights into all locum activity.
  • Finance / Operation Service Improvement:
    • Reduction in delayed staff payments due to removal of paper timesheets not arriving with finance in a timely fashion.
    • Reduced the time it takes to process weekly payrolls.
    • Captured escalations and virtually eliminated unwarranted and unauthorized escalations in participating departments.
    • Department managers have more visibility over the locum activity in their areas by accessing real-time and department-specific dashboards.
 
For other benefits please see previous sections.
See http://locumtap.com for further infiormation
 
Current and planned activity: 
Current Activity
Following a successfully implementation at Chelsea-Westminster Hospital Trust, we are now looking to expand across the UK and have initiated conversations with NHS trusts & STPs.
We are interested in being connected with healthcare organisations that are members of WM AHSN looking to improve on their staffing and agency operations and wish to reduce their spending.
 
Planned Activity
Thus we would like to discuss:
  • Procurement / Adoption -  LocumTap by WMAHSN Trusts, STP’s or CCGs
  • Concept Development Due to LocumTap’s flexibility & customisation, we welcome opportunities to discuss your requirements and how we may extend its capabilities for other health institutional requirements. We have plans to integrate Bank Nursing & Professions Allied to medicine and welcome input and interest in these services for your service 
What is the intellectual property status of your innovation?:
The software is copyrighted.
The system and  App is password protected and has basic encryption
Return on Investment (£ Value): 
Very high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Read more
Hide details
Jing Ouyang 08/09/2017 - 14:54 Publish Login or Register to post comments
0
0
Votes
-99999

Active Campaigns